0

SKA-121

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP1820708733
CAS1820708-73-3
Molecular Weight198.22
Description≥98% (HPLC)
SolubilityDMSO: 2 mg/mL, clear
Assay≥98% (HPLC)
Colorbrown to dark gray
Formpowder
Size5MG, 25MG
Storage Conditions2-8°C
1

Are There Superagonists for Calcium-Activated Potassium Channels?

Brandon M Brown, Heesung Shim, Heike Wulff

Channels (Austin). 2017 Nov 2;11(6):504-506.

PMID: 28876978

1

New Positive Ca2+-activated K+ Channel Gating Modulators With Selectivity for KCa3.1

Nichole Coleman, Brandon M Brown, Aida Oliván-Viguera, Vikrant Singh, Marilyn M Olmstead, Marta Sofia Valero, Ralf Köhler, Heike Wulff

Mol Pharmacol. 2014 Sep;86(3):342-57.

PMID: 24958817

1

Pharmacological Gating Modulation of Small- And Intermediate-Conductance Ca(2+)-activated K(+) Channels (KCa2.x and KCa3.1)

Palle Christophersen, Heike Wulff

Channels (Austin). 2015;9(6):336-43.

PMID: 26217968

1

Structural Determinants for the Selectivity of the Positive KCa3.1 Gating Modulator 5-Methylnaphtho[2,1- d]oxazol-2-amine (SKA-121)

Brandon M Brown, Heesung Shim, Miao Zhang, Vladimir Yarov-Yarovoy, Heike Wulff

Mol Pharmacol. 2017 Oct;92(4):469-480.

PMID: 28760780

1

Vascular Reactivity Profile of Novel KCa 3.1-Selective Positive-Gating Modulators in the Coronary Vascular Bed

Aida Oliván-Viguera, Marta Sofía Valero, Estéfano Pinilla, Sara Amor, Ángel Luis García-Villalón, Nichole Coleman, Celia Laría, Víctor Calvín-Tienza, Ángel-Luis García-Otín, José M Fernández-Fernández, etc.

Basic Clin Pharmacol Toxicol. 2016 Aug;119(2):184-92.

PMID: 26821335

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode